JP6188091B2 - メドキソミル基を有するプロドラッグを含有するフィルムコーティング製剤 - Google Patents

メドキソミル基を有するプロドラッグを含有するフィルムコーティング製剤 Download PDF

Info

Publication number
JP6188091B2
JP6188091B2 JP2015231235A JP2015231235A JP6188091B2 JP 6188091 B2 JP6188091 B2 JP 6188091B2 JP 2015231235 A JP2015231235 A JP 2015231235A JP 2015231235 A JP2015231235 A JP 2015231235A JP 6188091 B2 JP6188091 B2 JP 6188091B2
Authority
JP
Japan
Prior art keywords
tablet
coated
manufactured
type
sprayed
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JP2015231235A
Other languages
English (en)
Japanese (ja)
Other versions
JP2016135755A (ja
JP2016135755A5 (enExample
Inventor
一博 五丁森
一博 五丁森
孫市 酒向
孫市 酒向
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ohara Pharmaceutical Co Ltd
Original Assignee
Ohara Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ohara Pharmaceutical Co Ltd filed Critical Ohara Pharmaceutical Co Ltd
Publication of JP2016135755A publication Critical patent/JP2016135755A/ja
Publication of JP2016135755A5 publication Critical patent/JP2016135755A5/ja
Application granted granted Critical
Publication of JP6188091B2 publication Critical patent/JP6188091B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4178—1,3-Diazoles not condensed 1,3-diazoles and containing further heterocyclic rings, e.g. pilocarpine, nitrofurantoin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Inorganic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
JP2015231235A 2015-01-15 2015-11-27 メドキソミル基を有するプロドラッグを含有するフィルムコーティング製剤 Active JP6188091B2 (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2015005618 2015-01-15
JP2015005618 2015-01-15

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2017074205A Division JP2017119714A (ja) 2015-01-15 2017-04-04 メドキソミル基を有するプロドラッグを含有するフィルムコーティング製剤

Publications (3)

Publication Number Publication Date
JP2016135755A JP2016135755A (ja) 2016-07-28
JP2016135755A5 JP2016135755A5 (enExample) 2016-10-06
JP6188091B2 true JP6188091B2 (ja) 2017-08-30

Family

ID=56405574

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2015231235A Active JP6188091B2 (ja) 2015-01-15 2015-11-27 メドキソミル基を有するプロドラッグを含有するフィルムコーティング製剤
JP2017074205A Pending JP2017119714A (ja) 2015-01-15 2017-04-04 メドキソミル基を有するプロドラッグを含有するフィルムコーティング製剤

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2017074205A Pending JP2017119714A (ja) 2015-01-15 2017-04-04 メドキソミル基を有するプロドラッグを含有するフィルムコーティング製剤

Country Status (2)

Country Link
JP (2) JP6188091B2 (enExample)
WO (1) WO2016114017A1 (enExample)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP7209555B2 (ja) * 2019-01-18 2023-01-20 日本ジェネリック株式会社 ラメルテオン含有フィルムコーティング錠剤
TW202421201A (zh) * 2022-08-31 2024-06-01 南韓商賽特瑞恩股份有限公司 雙重氣味掩蔽醫藥組成物
WO2025137498A1 (en) * 2023-12-20 2025-06-26 Areteia Therapeutics, Inc. Matrix tablets of dexpramipexole and methods of manufacturing and use thereof

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH092976A (ja) * 1995-06-20 1997-01-07 Lion Corp 被覆組成物
JP4512265B2 (ja) * 2000-12-26 2010-07-28 株式会社ヤクルト本社 乳酸菌培養上清およびその製造方法並びに当該上清を利用する皮膚外用剤
JP2002201418A (ja) * 2000-12-28 2002-07-19 Nonogawa Shoji Kk コーティング剤及びこれを用いたコーティング錠
ES2510866T3 (es) * 2008-03-13 2014-10-21 Daiichi Sankyo Company, Limited Mejora de la solubilidad de una preparación que contiene olmesartán medoxomilo
JP5688799B2 (ja) * 2008-08-11 2015-03-25 第一三共株式会社 におい抑制方法
WO2014188728A1 (ja) * 2013-05-24 2014-11-27 持田製薬株式会社 フィルムコーティング用組成物

Also Published As

Publication number Publication date
JP2016135755A (ja) 2016-07-28
WO2016114017A1 (ja) 2016-07-21
JP2017119714A (ja) 2017-07-06

Similar Documents

Publication Publication Date Title
JP5677391B2 (ja) 光安定性に優れた医薬製剤
TWI405574B (zh) 藥學固體製劑及其製造方法
JP5854571B2 (ja) におい抑制方法
JP7383715B2 (ja) アファビシン製剤、その作製方法及びその使用
JP2018039823A (ja) メントールウィスカーの析出を抑制する方法
JPWO2009057569A1 (ja) フィルムコーティング製剤
JP2015061828A (ja) 口腔内崩壊錠及びその製造方法
JP2017119714A (ja) メドキソミル基を有するプロドラッグを含有するフィルムコーティング製剤
JP2016050206A (ja) レボカルニチンを含有する医薬錠剤
JP5248733B2 (ja) 揮散防止型固形製剤およびその製造方法
JP2017048174A (ja) 化学的に安定な原薬含有被覆粒子を含む口腔内崩壊錠剤
JP2010189443A (ja) 揮散防止型固形製剤およびその製造方法
JP2014224099A (ja) オルメサルタンメドキソミルを含有する医薬組成物
JP7066351B2 (ja) 良好な徐放性を有する、レボドパ含有小型化錠剤
WO2020111089A1 (ja) 医薬組成物
JP6600084B2 (ja) トスフロキサシントシル酸塩、崩壊剤および酸性アミノ酸を含む錠剤
JP2016102101A (ja) オルメサルタンメドキソミル含有錠剤
JP6176246B2 (ja) 固形医薬錠剤およびその製造方法
JP6336651B1 (ja) 化学的安定性が改善されたエソメプラゾール塩を含有する錠剤
JP2018172361A (ja) 光安定性を改善した、デュロキセチンを含有する固形製剤
JP2008133231A (ja) 光安定性が改善された医薬組成物
WO2023128898A1 (en) Pharmaceutical compositions comprising macitentan as active ingredient and other relevant excipients
JP2017132724A (ja) アムロジピン含有被覆造粒物を含む配合口腔内崩壊錠
JP2007290975A (ja) プランルカスト錠剤
JPWO2014007065A1 (ja) 固形医薬錠剤およびその製造方法

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20160818

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20160920

A871 Explanation of circumstances concerning accelerated examination

Free format text: JAPANESE INTERMEDIATE CODE: A871

Effective date: 20160920

A975 Report on accelerated examination

Free format text: JAPANESE INTERMEDIATE CODE: A971005

Effective date: 20161012

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20161108

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20161202

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20170126

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20170302

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20170615

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20170727

R150 Certificate of patent or registration of utility model

Ref document number: 6188091

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250